Apple has reportedly been working for many years to integrate non-invasive blood sugar monitoring into the Apple Watch. And according to a new report, the project may have recently reached a notable turning point.
The Apple Watch blood sugar monitoring project has a new leader, which some see as a key sign of progress.
This weekend, in his To Light Up newsletter, Mark Gurman wrote about the future of the Apple Watch. He explained what to expect from watchOS 27 and gave an update on a key project currently underway.
Mark Gurman writes to Bloomberg:
One potential breakthrough could come from Apple’s long-running non-invasive glucose monitoring project. First conceived during the Steve Jobs era, the effort aims to develop sensors that can detect elevated blood sugar levels without requiring finger pricks or blood draws.
Recently, Apple shifted project oversight from platform architecture chief Tim Millet to Zongjian Chen, the senior engineering manager overseeing the advanced technologies group and hardware such as modems. Some see the transition as a sign that work may finally be progressing to the point where Chen, known for keeping his promises, can accelerate the technology’s development toward an eventual mainstream offering.
This leadership transition was first mentioned in a report last week, among many other reshuffles driven by Johny Srouji. However, the context in which this decision is perceived within Apple is important.
If Chen is known within the company as “someone who keeps his promises” and this transition is seen as a sign of progress, then the transfer of responsibility from Millet to Chen could mark a key milestone.
This doesn’t mean we’ll see the Apple Watch get non-invasive blood sugar monitoring this year, or even next year. This could still take several years.
However, this accountability move is an encouraging sign of Apple’s significant progress toward achieving its ambitious goal.
Best Apple Watch accessories
